- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ExpreS2ion Biotech Holding AB (EXPRS2)
ExpreS2ion Biotech Holding AB stock price live, this page displays ST EXPRS2 stock exchange data. View the EXPRS2 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ExpreS2ion Biotech Holding AB real time stock price chart below.
What Is the ExpreS2ion Biotech Holding AB Stock Price Today?
The ExpreS2ion Biotech Holding AB stock price today is 1.40.
What Is the Stock Symbol for ExpreS2ion Biotech Holding AB?
The stock ticker symbol for ExpreS2ion Biotech Holding AB is EXPRS2.
Is EXPRS2 the Same as $EXPRS2?
$EXPRS2 is a common way to refer to the ExpreS2ion Biotech Holding AB ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does ExpreS2ion Biotech Holding AB Trade On?
ExpreS2ion Biotech Holding AB is listed and trades on the Stockholm stock exchange.
Is ExpreS2ion Biotech Holding AB a Good Stock to Buy?
Determining whether ExpreS2ion Biotech Holding AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current ExpreS2ion Biotech Holding AB share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EXPRS2 quote. (ISIN: SE0023261292)
What Is the ExpreS2ion Biotech Holding AB Stock Price Today?
The ExpreS2ion Biotech Holding AB stock price today is 1.40.
What Is the Stock Symbol for ExpreS2ion Biotech Holding AB?
The stock ticker symbol for ExpreS2ion Biotech Holding AB is EXPRS2.
Is EXPRS2 the Same as $EXPRS2?
$EXPRS2 is a common way to refer to the ExpreS2ion Biotech Holding AB ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does ExpreS2ion Biotech Holding AB Trade On?
ExpreS2ion Biotech Holding AB is listed and trades on the Stockholm stock exchange.
Is ExpreS2ion Biotech Holding AB a Good Stock to Buy?
Determining whether ExpreS2ion Biotech Holding AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current ExpreS2ion Biotech Holding AB share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EXPRS2 quote. (ISIN: SE0023261292)
Stockholm
Currency in SEK
1.40
+0.01(+0.72%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.33
1.45
52 wk Range
1.22
24.45
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.331.45
52 wk Range
1.2224.45
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EXPRS2 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
ExpreS2ion Biotech Holding AB Earnings Call Summary for Q2/2026
- Q2 net loss narrowed 3% to 9.7M SEK as grant income rose 407%, though operating loss widened to 12M SEK on 483% higher R&D spending.
- Lead cancer program ES2B-C001 showed antibody responses in 12 of 13 patients with no safety concerns; Phase II start delayed to H2 2027.
- Operating income surged 238% to 11.5M SEK, driven largely by grant-funded VICI-Disease CMC work rather than core commercial growth.
- Stock unchanged at $1.40, down 94% over past year; company completed 32.4M SEK rights issue with warrant exercise period set for August-September.
- Management expects end-2026 Phase I readout with translational data; actively pursuing partnerships but no deals announced or cash runway disclosed.
Last Updated: 08/20/2026, 04:40 AM
Read Full TranscriptEarnings
Latest Release
Aug 20, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare EXPRS2 to Peers and Sector
Metrics to compare | EXPRS2 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEXPRS2PeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −3.3x | −0.3x | |
PEG Ratio | −0.02 | 0.03 | 0.00 | |
Price / Book | 1.2x | 5.0x | 2.6x | |
Price / LTM Sales | 2.0x | 11.0x | 3.1x | |
Upside (Analyst Target) | 259.7% | 119.6% | 47.6% | |
Fair Value Upside | Unlock | 2.8% | 5.6% | Unlock |
ExpreS2ion Biotech Holding AB (publ), a clinical-stage biotechnology company, develops protein-based immunotherapies and vaccines for oncology and infectious diseases in the Nordics and internationally. The company’s lead asset is ES2B-C001, an immunotherapy candidate, which is in Phase 1 clinical trials for breast cancer that targets the human epidermal growth factor receptor 2, as well as vaccines for Nipah virus, Malaria, and influenza. It also offers GlycoX-S2, a glyco-engineered variants of the ExpreS2 platform to modify glycosylation patterns in expressed proteins. The company has collaboration agreement with University of Oxford for the development of vaccine for malaria. ExpreS2ion Biotech Holding AB (publ) was incorporated in 2015 is based in Helsingborg, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the ExpreS2ion Biotech (EXPRS2) Stock Price Today?
The ExpreS2ion Biotech stock price today is 1.40 SEK.
What Stock Exchange Does ExpreS2ion Biotech Trade On?
ExpreS2ion Biotech is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for ExpreS2ion Biotech?
The stock symbol for ExpreS2ion Biotech is "EXPRS2."
What Is the ExpreS2ion Biotech Market Cap?
As of today, ExpreS2ion Biotech market cap is 32.89M SEK.
What Is ExpreS2ion Biotech's Earnings Per Share (TTM)?
The ExpreS2ion Biotech EPS (TTM) is -10.26.
When Is the Next ExpreS2ion Biotech Earnings Date?
ExpreS2ion Biotech will release its next earnings report on Nov 12, 2026.
From a Technical Analysis Perspective, Is EXPRS2 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has ExpreS2ion Biotech Stock Split?
ExpreS2ion Biotech has split 4 times.
How Many Employees Does ExpreS2ion Biotech Have?
ExpreS2ion Biotech has 19 employees.
What is the current trading status of ExpreS2ion Biotech (EXPRS2)?
As of Aug 21, 2026, ExpreS2ion Biotech (EXPRS2) is trading at a price of 1.40 SEK, with a previous close of 1.39 SEK. The stock has fluctuated within a day range of 1.33 SEK to 1.45 SEK, while its 52-week range spans from 1.22 SEK to 24.45 SEK.
What Is ExpreS2ion Biotech (EXPRS2) Price Target According to Analysts?
The average 12-month price target for ExpreS2ion Biotech is 5.00 SEK, with a high estimate of 5 SEK and a low estimate of 5 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +257.14% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.